Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.63
0.03 (5.00%)
At close: Aug 15, 2025, 3:47 PM
0.61
-2.38%
After-hours: Aug 15, 2025, 03:47 PM EDT
Brainstorm Cell Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.09M | -11.62M | -14.23M | -12.75M | -15.53M | -17.19M | -16.63M | -22.26M | -23.98M | -24.28M | -25.45M | -23.93M | -23.16M | -24.46M | -30.08M | -29.23M | -30.36M |
Depreciation & Amortization | 228K | 240K | 253K | 259K | 262K | 265K | 269K | 274K | 278K | 285K | 285K | 282K | 273K | 260K | 254K | 243K | 231K |
Stock-Based Compensation | 1.3M | 750K | 492K | 862K | 1.66M | 1.49M | 1.92M | 1.76M | 1.18M | 1.68M | 1.95M | 1.75M | 1.8M | 1.58M | 1.31M | 2.13M | 2.46M |
Other Working Capital | 1.27M | 1.1M | 6.63M | 6.37M | 6.01M | 5.76M | -338K | -205K | -667K | -770K | -1.66M | -3.32M | -3.05M | -3.06M | -621K | -1.17M | -310K |
Other Non-Cash Items | -1.27M | -1.09M | -1.57M | -5.93M | -5.52M | -5.52M | -4.12M | 612K | 612K | 612K | -34K | n/a | -115K | -115K | -115K | -115K | 35K |
Deferred Income Tax | n/a | n/a | -1.58M | -1.58M | -1.58M | -1.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.17M | 2.63M | 5.3M | 4.7M | 1.19M | 2.08M | -3.26M | -648K | 2.29M | 2.38M | 3.07M | 109K | 213K | -3.54M | 302K | -1.82M | -1.5M |
Operating Cash Flow | -7.66M | -9.09M | -11.33M | -14.44M | -19.54M | -20.46M | -21.82M | -20.26M | -19.62M | -19.32M | -20.18M | -21.79M | -20.98M | -26.27M | -28.34M | -28.8M | -29.13M |
Capital Expenditures | n/a | n/a | n/a | -18K | -18K | -18K | 11K | 28K | 9K | n/a | -64K | -300K | -309K | -330K | -528K | -379K | -401K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 196K | 202K | 202K | 202K | 6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 12K | 12K | n/a | n/a | 4K | 2.01M | 3.02M | 3.01M | 3.01M | 998K | -1.27M | 670K | 652K | 653K | 1.85M | -85K | -2.09M |
Investing Cash Flow | 12K | 12K | 196K | 184K | 188K | 2.19M | 3.04M | 3.04M | 3.02M | 998K | -1.34M | 370K | 343K | 323K | 1.32M | -464K | -2.5M |
Debt Repayment | 900K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -106K | -106K | -106K | -222K | -116K | -116K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16K | 6.34M | 6.34M |
Financial Cash Flow | 8.51M | 7.97M | 10.26M | 17.36M | 18.29M | 18.98M | 15.86M | 8.77M | 3.47M | 238K | -34K | -140K | -140K | 6.97M | 27.94M | 47.67M | 55.09M |
Net Cash Flow | 865K | -1.11M | -1.06M | 2.92M | -1.25M | 528K | -2.92M | -8.46M | -13.13M | -18.08M | -21.55M | -21.56M | -20.78M | -18.97M | 925K | 18.41M | 23.46M |
Free Cash Flow | -7.66M | -9.09M | -11.33M | -14.46M | -19.55M | -20.48M | -21.84M | -20.26M | -19.64M | -19.35M | -20.24M | -22.09M | -21.29M | -26.59M | -28.86M | -29.18M | -29.53M |